Cargando…

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

SUMMARY: We report the changes in biochemical markers of bone formation during the first 6 months of teriparatide therapy in postmenopausal women with osteoporosis according to previous antiresorptive treatment. Prior therapy does not adversely affect the response to teriparatide treatment. Similar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blumsohn, A., Marin, F., Nickelsen, T., Brixen, K., Sigurdsson, G., González de la Vera, J., Boonen, S., Liu-Léage, S., Barker, C., Eastell, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092934/ https://www.ncbi.nlm.nih.gov/pubmed/20938767 http://dx.doi.org/10.1007/s00198-010-1379-y

Ejemplares similares

Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
por: Eastell, R., et al.
Publicado: (2019)

Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life
por: Panico, Annalisa, et al.
Publicado: (2011)

Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
por: Sugimoto, T., et al.
Publicado: (2013)

Bone turnover in elderly men: relationships to change in bone mineral density
por: Nguyen, Tuan V, et al.
Publicado: (2007)

Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma
por: Kim, Chei Won, et al.
Publicado: (2015)

Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study
por: Dito, Giorgia, et al.
Publicado: (2023)

Association of bone mineral density with biochemical markers of bone turnover in hemodialysis children
por: Hajizadeh, Niloofar, et al.
Publicado: (2016)

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
por: Lu, Chunyan, et al.
Publicado: (2017)

Bone turnover in passive smoking female rat: relationships to change in bone mineral density
por: Gao, Shu-guang, et al.
Publicado: (2011)

Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men
por: Pye, S. R., et al.
Publicado: (2016)

Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
por: Shiraki, M., et al.
Publicado: (2012)

Effect of Teriparatide on Bone Mineral Density and Bone Markers in Real-Life: Argentine Experience
por: Guelman, Rodolfo, et al.
Publicado: (2023)

Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
por: Kamimura, Mikio, et al.
Publicado: (2018)

Changes in bone mineral density and bone turnover markers in patients undergoing hematopoietic stem cell transplant
por: Pandit, Aditi, et al.
Publicado: (2015)

The Change of Bone Metabolism in Ovariectomized Rats : Analyses of MicroCT Scan and Biochemical Markers of Bone Turnover
por: Yoon, Kyung-Hyuk, et al.
Publicado: (2012)

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis
por: Farahmand, P., et al.
Publicado: (2013)

A hospital based study of biochemical markers of bone turnovers & bone mineral density in north Indian women
por: Kumar, Ashok, et al.
Publicado: (2013)

Relationship of High Circulating Cystatin C to Biochemical Markers of Bone Turnover and Bone Mineral Density in Elderly Males with a Chronic Heart Failure
por: Nedeljkovic, Biljana Bozic, et al.
Publicado: (2019)

Bone Turnover Markers: Basic Biology to Clinical Applications
por: Schini, Marian, et al.
Publicado: (2022)

Evaluation of bone mineral density and bone turnover in children on anticoagulation
por: Thom, Katharina, et al.
Publicado: (2023)

Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis
por: Moore, Amelia E. B., et al.
Publicado: (2011)

Biochemical markers of bone turnover and their association with bone marrow lesions
por: Hunter, David J, et al.
Publicado: (2008)

Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone
por: Starup-Linde, Jakob
Publicado: (2013)

24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk
por: Sugimoto, Toshitsugu, et al.
Publicado: (2017)

The Change of Bone Turnover Markers and Bone Remodelling Balance in Acromegaly
por: Chen, Huan, et al.
Publicado: (2021)

Bone turnover markers in serum but not in saliva correlate with bone mineral density
por: Kerschan-Schindl, Katharina, et al.
Publicado: (2020)

Bone Turnover Markers and Bone Mineral Density in Children with Hypophosphatemic Rickets
por: Michałus, Izabela, et al.
Publicado: (2022)

Changes in bone turnover markers and bone modulators during abatacept treatment
por: Adami, Giovanni, et al.
Publicado: (2023)

Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
por: McClung, M. R., et al.
Publicado: (2012)

Bone turnover and bone mineral density in old persons with type 2 diabetes
por: Martins, João Martin, et al.
Publicado: (2018)

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
por: Austin, Matthew, et al.
Publicado: (2012)

Declining serum bone turnover markers are associated with the short-term positive change of lumbar spine bone mineral density in postmenopausal women
por: Zhao, Shengli, et al.
Publicado: (2022)

Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats
por: Shimizu, T., et al.
Publicado: (2017)

The Assessment of Bone Regulatory Pathways, Bone Turnover, and Bone Mineral Density in Vegetarian and Omnivorous Children
por: Ambroszkiewicz, Jadwiga, et al.
Publicado: (2018)

Changes in markers of bone turnover during treatment of hyperthyroidism
por: Onal, Eda Demir
Publicado: (2012)

Significant Loss of Areal Bone Mineral Density Following Prolonged Bed Rest During Treatment With Teriparatide
por: Martin, Christopher T., et al.
Publicado: (2017)

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club
por: Bergmann, P, et al.
Publicado: (2009)

Does bone scintigraphy show Modic changes associated with increased bone turnover?
por: Järvinen, Jyri, et al.
Publicado: (2020)

Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice()
por: Arlt, Heike, et al.
Publicado: (2020)

Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese women
por: Hinton, Pamela S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2qhvqusu50spris4tj3e3n9uj2